Charter Oak Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Sell
48,284
-579
-1% -$34K 0.2% 38
2025
Q4
$3.04M Sell
48,863
-5,208
-10% -$322K 0.23% 36
2025
Q3
$3.25M Sell
54,071
-3,960
-7% -$242K 0.25% 34
2025
Q2
$3.64M Sell
58,031
-1,646
-3% -$98.9K 0.31% 31
2025
Q1
$3.59M Sell
59,677
-2,010
-3% -$125K 0.33% 27
2024
Q4
$3.6M Sell
61,687
-4,826
-7% -$287K 0.34% 29
2024
Q3
$3.94M Sell
66,513
-3,053
-4% -$174K 0.37% 25
2024
Q2
$3.9M Sell
69,566
-7,654
-10% -$428K 0.41% 25
2024
Q1
$4.52M Sell
77,220
-1,312
-2% -$74.1K 0.48% 23
2023
Q4
$4.24M Sell
78,532
-3,543
-4% -$173K 0.5% 23
2023
Q3
$3.98M Sell
82,075
-2,503
-3% -$133K 0.53% 23
2023
Q2
$4.78M Sell
84,578
-134
-0.2% -$7.38K 0.62% 21
2023
Q1
$4.57M Sell
84,712
-537
-0.6% -$28.6K 0.63% 21
2022
Q4
$4.48M Sell
85,249
-1,336
-2% -$67.8K 0.67% 23
2022
Q3
$4.08M Buy
86,585
+11
+0% +$571 0.65% 24
2022
Q2
$4.37M Buy
86,574
+473
+0.5% +$25.8K 0.6% 24
2022
Q1
$5.25M Buy
86,101
+856
+1% +$51K 0.64% 23
2021
Q4
$5.61M Buy
85,245
+2,760
+3% +$177K 0.65% 23
2021
Q3
$5.18M Buy
82,485
+2,391
+3% +$153K 0.65% 24
2021
Q2
$4.82M Buy
80,094
+3,282
+4% +$190K 0.62% 25
2021
Q1
$4.23M Buy
76,812
+5,610
+8% +$311K 0.59% 26
2020
Q4
$3.88M Buy
+71,202
New +$3.72M 0.59% 25

Other funds holding IHI

Charter Oak Capital Management's IHI Position: Q1 2026 in Review

Charter Oak Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 1.2% in Q1 2026, selling an estimated $34K and leaving 48,284 shares worth $2.58M. The position accounts for 0.2% of the portfolio, ranked #38.

Charter Oak Capital Management first reported a position in IHI in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.61M in Q4 2021. 509 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Charter Oak Capital Management held 48,284 shares of iShares US Medical Devices ETF worth $2.58M as of Q1 2026.
  • Charter Oak Capital Management sold 579 iShares US Medical Devices ETF shares in Q1 2026, an estimated $34K.
  • iShares US Medical Devices ETF made up 0.2% of Charter Oak Capital Management's portfolio in Q1 2026, its #38 holding.
  • Charter Oak Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 22 quarters since.
  • Charter Oak Capital Management's iShares US Medical Devices ETF position peaked at $5.61M in Q4 2021.
  • 509 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.